Detalhe da pesquisa
1.
The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.
Brain Behav Immun
; 77: 110-126, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30582962
2.
Brain-borne IL-1 adjusts glucoregulation and provides fuel support to astrocytes and neurons in an autocrine/paracrine manner.
Mol Psychiatry
; 21(9): 1309-20, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26643538
3.
Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
Brain Behav Immun
; 49: 233-45, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26086345
4.
Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.
Clin Exp Immunol
; 175(2): 202-7, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24188195
5.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Neurobiol Dis
; 59: 141-50, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23851307
6.
Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology.
Mol Psychiatry
; 17(7): 705-18, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22005929
7.
Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia.
Mol Psychiatry
; 15(4): 372-83, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18414405
8.
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis.
Neurobiol Dis
; 37(1): 166-76, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19815071
9.
A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.
Mol Cell Neurosci
; 40(2): 258-66, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19059482
10.
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.
Br J Pharmacol
; 153(2): 216-25, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17891163
11.
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.
Biochem Pharmacol
; 157: 51-66, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30171835
12.
Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.
Sci Rep
; 7: 44377, 2017 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-28290524
13.
Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats.
Behav Brain Res
; 172(1): 46-53, 2006 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16730079
14.
[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis]. / El sistema cannabinoide en situaciones de neuroinflamación: perspectivas terapéuticas en la esclerosis múltiple.
Rev Neurol
; 43(9): 541-8, 2006.
Artigo
Espanhol
| MEDLINE | ID: mdl-17072810
15.
Microglia activation states and cannabinoid system: Therapeutic implications.
Pharmacol Ther
; 166: 40-55, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27373505
16.
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Br J Pharmacol
; 172(14): 3579-95, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25857324
17.
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.
Br J Pharmacol
; 172(17): 4277-90, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25994655
18.
Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids.
Endocrinology
; 131(2): 677-83, 1992 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-1639014
19.
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway.
FEBS Lett
; 433(1-2): 139-42, 1998 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-9738948
20.
Role of arachidonic acid metabolism on corticotropin-releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami.
J Neuroimmunol
; 39(1-2): 57-66, 1992 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-1619039